NLS Days Reception at the Norwegian Ambassador's Residence
7 September 2026, 16:00 - 18:00 GMT+01:00
Seminar
The Royal Norwegian Embassy in Stockholm is pleased to host an exclusive networking reception at The Royal Norwegian Ambassador’s Residence.
This reception will bring together selected guests from across the life sciences ecosystem, including investors, founders, industry leaders and partners attending NLS Days.
The afternoon offers an opportunity to connect in an informal and distinguished setting, exchange insights, and explore opportunities for collaboration across the Nordic life sciences community.
As part of the programme, a panel discussion will explore Norwegian strengths within life sciences, featuring:
- Karin Leire, Segulah Medical (Sweden)
- Pekka Simula, Innovestor (Finland)
- Renée Amundsen, Lytix Biopharma (Norway)
- Moderated by Chelsea Ranger, Ranger Consulting
Please note that attendance is by invitation only and places are limited. The first registration deadline is 17 August. Following this date, participation will be confirmed for the first registered guests, subject to availability. To express your interest, please click "Register participation". Final deadline for registration is 2 September.
We look forward to welcoming you to an engaging afternoon at the Norwegian Ambassador's Residence in Stockholm.
Address:
Kongelig norsk ambassade i Stockholm
Skarpögatan 4
115 27 Stockholm
Tone Varslot Stave
Head of national export initiative on health and life science, Innovation Norway
Important conditions
Companies must adhere to standards for responsible business conduct, including Environmental, Social, and Governance (ESG) criteria.
Participants are expected to operate in accordance with the UN Guiding Principles on Business and Human Rights and the OECD Guidelines for Multinational Enterprises on Responsible Business Conduct. This entails conducting business responsibly, respecting human rights, ensuring decent working conditions, safeguarding environmental considerations, and actively preventing corruption.
Companies must carry out their own due diligence assessments (risk assessments) to identify, prevent, and mitigate potential adverse impacts.